• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过在人工脂质双层中共包被腺病毒和小干扰RNA来开发双活性载体。

Development of dual-activity vectors by co-envelopment of adenovirus and SiRNA in artificial lipid bilayers.

作者信息

Yilmazer Açelya, Tian Bowen, Kostarelos Kostas

机构信息

Nanomedicine Laboratory, Faculty of Life Sciences, University College London, London, United Kingdom.

School of Pharmacy, University of Nottingham, Nottingham, United Kingdom.

出版信息

PLoS One. 2014 Dec 12;9(12):e114985. doi: 10.1371/journal.pone.0114985. eCollection 2014.

DOI:10.1371/journal.pone.0114985
PMID:25501573
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4264847/
Abstract

Gene therapy with human adenovirus type 5 (Ad5) has been extensively explored for the treatment of diseases resistant to traditional therapies. Intravenous administration leads to rapid clearance from blood circulation and high liver accumulation, which restrict the use of Ad-based vectors in clinical gene therapy protocols that involve systemic administration. We have previously proposed that such limitations can be improved by engineering artificial lipid envelopes around Ad and designed a variety of artificial lipid bilayer envelopes around the viral capsid. In this study, we sought to explore further opportunities that the artificially enveloped virus constructs could offer, by designing a previously unreported gene therapy vector by simultaneous envelopment of Ad and siRNA within the same lipid bilayer. Such a dual-activity vector can offer efficacious therapy for different genetic disorders where both turning on and switching off genes would be needed. Dynamic light scattering, transmission electron microscopy and atomic force microscopy were used to characterize these vectors. Agarose gel electrophoresis, Ribo green and dot blot assays showed that siRNA and Ad virions can be enveloped together within lipid bilayers at high envelopment efficiency. Cellular uptake and in vitro transfection experiments were carried out to show the feasibility of combining siRNA-mediated gene silencing with viral gene transfer using these newly designed dual-activity vectors.

摘要

利用人5型腺病毒(Ad5)进行基因治疗已被广泛探索用于治疗对传统疗法耐药的疾病。静脉内给药会导致其从血液循环中迅速清除并在肝脏中大量蓄积,这限制了基于Ad的载体在涉及全身给药的临床基因治疗方案中的应用。我们之前曾提出,通过在Ad周围构建人工脂质包膜可以改善这些局限性,并围绕病毒衣壳设计了多种人工脂质双分子层包膜。在本研究中,我们试图通过设计一种以前未报道的基因治疗载体来进一步探索人工包膜病毒构建体可能带来的机会,即将Ad和siRNA同时包裹在同一脂质双分子层中。这种双活性载体可以为需要开启和关闭基因的不同遗传疾病提供有效的治疗。利用动态光散射、透射电子显微镜和原子力显微镜对这些载体进行了表征。琼脂糖凝胶电泳、Ribo green和斑点印迹分析表明,siRNA和Ad病毒粒子可以以高包裹效率共同包裹在脂质双分子层内。进行了细胞摄取和体外转染实验,以证明使用这些新设计的双活性载体将siRNA介导的基因沉默与病毒基因转移相结合的可行性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee71/4264847/f77ab60e4ad5/pone.0114985.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee71/4264847/509ff0203b0d/pone.0114985.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee71/4264847/19b36e830e43/pone.0114985.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee71/4264847/e6271f16d4ef/pone.0114985.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee71/4264847/dca37b45127e/pone.0114985.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee71/4264847/41fb13f69865/pone.0114985.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee71/4264847/f77ab60e4ad5/pone.0114985.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee71/4264847/509ff0203b0d/pone.0114985.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee71/4264847/19b36e830e43/pone.0114985.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee71/4264847/e6271f16d4ef/pone.0114985.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee71/4264847/dca37b45127e/pone.0114985.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee71/4264847/41fb13f69865/pone.0114985.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee71/4264847/f77ab60e4ad5/pone.0114985.g006.jpg

相似文献

1
Development of dual-activity vectors by co-envelopment of adenovirus and SiRNA in artificial lipid bilayers.通过在人工脂质双层中共包被腺病毒和小干扰RNA来开发双活性载体。
PLoS One. 2014 Dec 12;9(12):e114985. doi: 10.1371/journal.pone.0114985. eCollection 2014.
2
The effect of artificial lipid envelopment of Adenovirus 5 (Ad5) on liver de-targeting and hepatotoxicity.腺病毒 5(Ad5)的人工脂质包膜对肝脏脱靶和肝毒性的影响。
Biomaterials. 2013 Jan;34(4):1354-63. doi: 10.1016/j.biomaterials.2012.10.053. Epub 2012 Nov 9.
3
Artificial envelopment of nonenveloped viruses: enhancing adenovirus tumor targeting in vivo.无包膜病毒的人工包膜:增强腺病毒在体内的肿瘤靶向性
FASEB J. 2008 Sep;22(9):3389-402. doi: 10.1096/fj.08-103275. Epub 2008 Jun 12.
4
Intracellular trafficking and gene expression of pH-sensitive, artificially enveloped adenoviruses in vitro and in vivo.pH 敏感型人工包膜腺病毒的细胞内运输和基因表达:体内外研究
Biomaterials. 2011 Apr;32(11):3085-93. doi: 10.1016/j.biomaterials.2010.12.043. Epub 2011 Jan 26.
5
Nanoengineering artificial lipid envelopes around adenovirus by self-assembly.通过自组装对腺病毒进行纳米工程人工脂质包膜。
ACS Nano. 2008 May;2(5):1040-50. doi: 10.1021/nn8000565.
6
Investigation of the performance of PEG-PEI/ROCK-II-siRNA complexes for Alzheimer's disease in vitro.聚乙二醇-聚醚酰亚胺/ROCK-II-siRNA 复合物治疗阿尔茨海默病的体外性能研究。
Brain Res. 2013 Jan 15;1490:43-51. doi: 10.1016/j.brainres.2012.10.039. Epub 2012 Oct 26.
7
Adenovirus vectors based on human adenovirus type 19a have high potential for human muscle-directed gene therapy.基于人19a型腺病毒的腺病毒载体在人类肌肉定向基因治疗方面具有很高的潜力。
Hum Gene Ther. 2006 Feb;17(2):193-205. doi: 10.1089/hum.2006.17.193.
8
siRNA delivery by a transferrin-associated lipid-based vector: a non-viral strategy to mediate gene silencing.通过转铁蛋白相关脂质载体递送小干扰RNA:一种介导基因沉默的非病毒策略。
J Gene Med. 2007 Mar;9(3):170-83. doi: 10.1002/jgm.1006.
9
Genome size and structure determine efficiency of postinternalization steps and gene transfer of capsid-modified adenovirus vectors in a cell-type-specific manner.基因组大小和结构以细胞类型特异性方式决定内化后步骤的效率以及衣壳修饰腺病毒载体的基因转移效率。
J Virol. 2004 Sep;78(18):10009-22. doi: 10.1128/JVI.78.18.10009-10022.2004.
10
Intraperitoneal in vivo gene therapy to deliver alpha 1-antitrypsin to the systemic circulation.通过腹腔内体内基因治疗将α1-抗胰蛋白酶递送至体循环。
Am J Respir Cell Mol Biol. 1994 Apr;10(4):369-77. doi: 10.1165/ajrcmb.10.4.8136153.

本文引用的文献

1
Armed therapeutic viruses - a disruptive therapy on the horizon of cancer immunotherapy.武装治疗性病毒——癌症免疫治疗领域即将出现的一种突破性疗法。
Front Immunol. 2014 Feb 24;5:74. doi: 10.3389/fimmu.2014.00074. eCollection 2014.
2
Liposomal siRNA nanocarriers for cancer therapy.用于癌症治疗的脂质体小干扰RNA纳米载体
Adv Drug Deliv Rev. 2014 Feb;66:110-6. doi: 10.1016/j.addr.2013.12.008. Epub 2013 Dec 30.
3
Stable RNA nanoparticles as potential new generation drugs for cancer therapy.稳定的RNA纳米颗粒作为癌症治疗的潜在新一代药物。
Adv Drug Deliv Rev. 2014 Feb;66:74-89. doi: 10.1016/j.addr.2013.11.006. Epub 2013 Nov 22.
4
Carbon nanotubes as vectors for gene therapy: past achievements, present challenges and future goals.碳纳米管作为基因治疗的载体:过去的成就、现在的挑战和未来的目标。
Adv Drug Deliv Rev. 2013 Dec;65(15):2023-33. doi: 10.1016/j.addr.2013.10.003. Epub 2013 Oct 31.
5
Delivery materials for siRNA therapeutics.siRNA 治疗药物的递送材料。
Nat Mater. 2013 Nov;12(11):967-77. doi: 10.1038/nmat3765.
6
A potential therapeutic strategy for malignant mesothelioma with gene medicine.用基因医学治疗恶性间皮瘤的一种潜在治疗策略。
Biomed Res Int. 2013;2013:572609. doi: 10.1155/2013/572609. Epub 2013 Jan 16.
7
Degradable terpolymers with alkyl side chains demonstrate enhanced gene delivery potency and nanoparticle stability.具有烷基侧链的可降解三元共聚物表现出增强的基因传递效力和纳米颗粒稳定性。
Adv Mater. 2013 Mar 13;25(10):1487-93. doi: 10.1002/adma.201204346. Epub 2013 Jan 4.
8
The effect of artificial lipid envelopment of Adenovirus 5 (Ad5) on liver de-targeting and hepatotoxicity.腺病毒 5(Ad5)的人工脂质包膜对肝脏脱靶和肝毒性的影响。
Biomaterials. 2013 Jan;34(4):1354-63. doi: 10.1016/j.biomaterials.2012.10.053. Epub 2012 Nov 9.
9
Simultaneous gene transduction and silencing using stimuli-responsive viral/nonviral chimeric nanoparticles.利用刺激响应型病毒/非病毒嵌合纳米颗粒进行基因的同时转导和沉默。
Biomaterials. 2012 Apr;33(11):3316-23. doi: 10.1016/j.biomaterials.2012.01.027. Epub 2012 Jan 24.
10
Co-delivery of small interfering RNA and plasmid DNA using a polymeric vector incorporating endosomolytic oligomeric sulfonamide.聚合物载体共递送小干扰 RNA 和质粒 DNA 结合内溶酶体聚合的磺酰胺
Biomaterials. 2011 Jul;32(21):4914-24. doi: 10.1016/j.biomaterials.2011.03.042. Epub 2011 Apr 12.